BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8299722)

  • 1. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
    Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
    Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2/M.
    Shinomiya N; Takemura T; Iwamoto K; Rokutanda M
    Cytometry; 1997 Apr; 27(4):365-73. PubMed ID: 9098629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
    Takahashi M; Yamamoto Y; Hatori S; Shiozawa M; Suzuki M; Rino Y; Amano T; Imada T
    Oncol Rep; 1998; 5(1):53-6. PubMed ID: 9458292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines.
    Janss AJ; Levow C; Bernhard EJ; Muschel RJ; McKenna WG; Sutton L; Phillips PC
    Exp Cell Res; 1998 Aug; 243(1):29-38. PubMed ID: 9716446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
    Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
    Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
    Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
    Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma.
    Tomita K; Tsuchiya H
    Clin Ther; 1989; 11(1):43-52. PubMed ID: 2720727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells.
    Yasutake H; Tsuchiya H; Tomita K; Matsunaga T; Nikaido O; Mori T
    Anticancer Res; 1995; 15(3):831-7. PubMed ID: 7645967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined effect of cisplatin and caffeine on murine B16-BL6 melanoma cells].
    Yasutake H; Tsuchiya H; Sugihara M; Tomita K; Ueda Y; Tanaka M; Sasaki T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2031-8. PubMed ID: 2730093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis].
    Yamamoto Y; Amano T; Imada T; Akaike M; Noguchi Y; Aoyama N; Tsuburaya A; Rino Y; Takehana T; Hasuo K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1825-31. PubMed ID: 1877825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.